Related by context. All words. (Click for frequent words.) 68 Comorbid 66 Treating Chronic 65 Psychiatric Disorders 65 Differential Diagnosis 65 Bipolar Mania 65 Often Misdiagnosed 64 rheumatoid arthritis osteoarthritis ankylosing 64 Chronic Wounds 64 Slow Progression 64 Generalized Anxiety Disorder 64 Rare Genetic 64 Major Depressive Disorder 64 #:#-#,# CrossRef Medline [002] 63 Bronchiectasis 63 comorbid anxiety 63 Treatment Resistant 63 hyperammonemia 63 Thrombocytopenia 63 Hypotension 63 paroxysmal nocturnal hemoglobinuria 63 Chronic Renal Failure 63 Services #:#-#,# Abstract 63 Idiopathic 63 Schizoaffective Disorder 63 Relapsing Multiple Sclerosis 63 Overactive Bladder 62 Ischemic 62 Chronic Insomnia 62 Hyperkalemia 62 Antidepressants Linked 62 Sleep Disturbances 62 Vertebral Fractures 62 Improves Outcomes 62 Reduces Mortality 62 Secondary Hyperparathyroidism 62 Angioedema 62 Hepatic Encephalopathy 62 Hypercholesterolemia 62 Cognitive Impairment 62 Drug Prevents 62 Systematic Review 62 Comorbidities 62 induce orthostatic hypotension 62 Liver Injury 62 Urinary Incontinence 62 Randomized Controlled Trials 62 Conduct Disorder 62 Panic Disorder 62 Ileus 62 Research www. elsevier.com 62 Unstable Angina 61 Demonstrates Positive 61 HeFH 61 Ischemic Stroke 61 Hypoactive Sexual Desire Disorder 61 Am J Geriatr 61 Migraine Headache 61 See CLINICAL PHARMACOLOGY 61 somatization disorder 61 Mitral Regurgitation 61 #:#-#,# CrossRef Medline [001] 61 Exacerbation 61 Immunologic 61 Generalized Anxiety Disorder GAD 61 Thrombotic 61 Magnetic Stimulation 61 Gene Mutation Linked 61 proliferative retinopathy 61 Depressive Symptoms 61 Prophylactic Treatment 61 Diabetic Foot Ulcer 61 Chronic Constipation 61 Bone Metastases 61 AA Amyloidosis 61 Overactive Bladder OAB 61 Hypertrophic 61 Treatment Shows Promise 61 dual endothelin receptor antagonist 61 Nonalcoholic Fatty Liver Disease 61 Posttraumatic stress disorder 61 Obstructive Sleep Apnea 61 leukopenia pancytopenia thrombocytopenia 61 Soft Tissue Sarcoma 61 Mucositis 60 comorbid psychiatric disorders 60 Gene Linked 60 Suicidality 60 Chronic Sinusitis 60 Meets Primary Endpoint 60 hyperphenylalaninemia HPA due 60 Endometrial Cancer 60 complement inhibitor eculizumab 60 #-# Full Text 60 Comorbidity 60 Dyslipidemia 60 Prehypertension 60 Clinical Outcome 60 Myelodysplastic Syndrome MDS 60 Systemic Lupus Erythematosus SLE 60 myofascial pain syndrome 60 Atomoxetine 60 Patients Undergoing 60 Oral Fingolimod 60 dysthymic disorder 60 #:#-# [023] 60 Genetic Markers 60 comorbid depression 60 bacterial prostatitis 60 Renal Cell Carcinoma 60 Orthostatic Hypotension 60 Bipolar Depression 60 Migraine Headaches 60 Chronic Myeloid Leukemia 60 Hyperlipidemia 60 Subgroup Analysis 60 Anxiety Depression 60 Benign Prostatic Hyperplasia 60 significant cytopenia eg 60 Acromegaly 60 Carotid Stenting 60 Chemotherapy induced 60 Neurocognitive 60 Venous thromboembolism 60 lichen planus 60 Valvular 60 Pleural Mesothelioma 60 Myocardial Ischemia 60 Arch Neurol 60 osteoporotic vertebral fractures 60 Systemic Sclerosis 60 Catheter Associated 60 #:#-#,# [002] 60 receiving XGEVA 60 torsade de pointes 60 Prolongs Survival 60 Cardiac Stem Cell 60 Chronic Inflammatory 60 John M Grohol 59 Atopic Dermatitis 59 Heavy menstrual bleeding 59 Malignant Glioma 59 Cariprazine 59 Diagnostic Criteria 59 ST Segment Elevation 59 Treatable 59 NOMID 59 Uterine Fibroids 59 Adjunctive 59 Adenomas 59 Juvenile Idiopathic Arthritis 59 Therapy Improves 59 pulmonary hypertension PH 59 Hepatotoxicity 59 J Clin 59 Myelofibrosis 59 juvenile idiopathic arthritis 59 Hormone Refractory Prostate Cancer 59 gastro oesophageal reflux 59 Asymptomatic 59 Major Depressive Disorder MDD 59 Spasticity 59 leiomyomas 59 Pharmacologic 59 Clinical Trial Data 59 Growth Hormone Deficiency 59 Ovarian cysts 59 Patients Receiving 59 Kidney Stones 59 Shows Promise Against 59 Major Depressive 59 Newly Diagnosed 59 Diastolic Heart Failure 59 Testosterone deficiency 59 Fibromyalgia Syndrome 59 Exacerbations 59 Severe Acne 59 Phase 2b Clinical Trial 59 undergoing Percutaneous Coronary 59 Trigeminal Neuralgia 59 Metabolic Disorder 59 Childhood Trauma 59 Ventricular Arrhythmias 59 bullous 59 Irritable bowel syndrome IBS 59 Tardive Dyskinesia 59 CYT# potent vascular disrupting 59 Investigational Treatment 59 Non inferiority 59 Drug Shows Promise 59 Obesity Linked 59 Iron Overload 59 B Cell Lymphoma 59 Chronic Myelogenous Leukemia 59 Prognostic Factors 59 Short Stature 59 EXJADE 59 Resistant Hypertension 59 Knee Osteoarthritis 59 Endocrinol 58 Escitalopram 58 Intravenous immunoglobulin 58 Sleep Problems 58 Diabetic Kidney Disease 58 Microalbuminuria 58 Hypertrophy 58 Mouse Model 58 Liver Failure 58 Peripheral Arterial 58 Major depressive disorder 58 Decompensated Heart Failure 58 Mild Cognitive Impairment 58 Obstructive sleep apnea OSA 58 Not Otherwise Specified 58 Neovascular Age Related Macular 58 parkinson disease 58 Diabetic Macular Edema 58 Carotid Artery Disease 58 Rheumatoid 58 haematologic 58 diabetes mellitus DM 58 Carotid Endarterectomy 58 Primary Biliary Cirrhosis 58 convulsive disorders 58 Valvular Heart Disease 58 Prospective Randomized 58 cervicitis 58 aspartate aminotransferase AST 58 Chronic Lyme Disease 58 Posttraumatic 58 JAK2 Inhibitor 58 Premenstrual 58 Excessive Sleepiness 58 Electrical Stimulation 58 Disord 58 Pervasive Developmental Disorders 58 Hormone Replacement 58 Risk Stratification 58 Nonspecific 58 Tardive dyskinesia 58 Suicidal Ideation 58 Cognitive Problems 58 hypertension osteoarthritis 58 Bipolar Disorders 58 Neuropathic 58 Fecal Incontinence 58 variceal bleeding 58 Aggressive Reduction 58 prolonged QT interval 58 #:#-#,# [003] 58 Psychotic Disorders 58 Chronic Pelvic Pain 58 syncopal episodes 58 Stress urinary incontinence 58 Dysmenorrhea 58 Venous Thromboembolism 58 Mood disorders 58 Left Ventricular 58 acute mania 58 Severe Primary IGFD 58 Coronary Artery Bypass Graft 58 Patient Outcomes 58 Cutaneous T 58 Diabetic Nephropathy 58 acute subacute 58 LVNC 58 Antisocial personality 58 Breast Cancer Recurrence 58 dysmenorrhoea 58 Clin J 58 Initiates Clinical Trial 58 J Neurosurg 58 Phase IIa Clinical Trial 58 Cardiovascular Outcomes 58 Intracerebral Hemorrhage 58 Dementia Diagnosis 58 Elderly Patients 58 schizophrenia schizoaffective disorder 58 Social Phobia 58 Neovascular AMD 58 Genes Linked 58 Generalized anxiety disorder 58 Gene Mutation 58 thrombocytosis 58 Interstitial cystitis 58 Chronic pelvic 58 Metastases 58 Cognitive Decline 58 Allergic Rhinitis 58 Gene Variation 58 GH deficiency 58 Diabetic Neuropathy 58 Proteinuria 58 Combination Treatment 58 CP CPPS 58 Rheumatoid Arthritis Patients 58 Arrhythmias 58 Renal Artery 58 Muscle Wasting 58 Coronary Arteries 58 Meta Analysis 58 rheumatoid arthritis inflammatory bowel 58 ANN INTERN MED 57 elevated ALT 57 T1DM 57 Adrenal Fatigue 57 Antitumor Activity 57 Heart Failure Patients 57 venlafaxine Effexor 57 Advanced Melanoma 57 Chronic Heart Failure 57 Bruxism 57 By Peggy Bresnick 57 Irritability anxiety cognitive 57 Minimally Invasive Treatment 57 Female Sexual Arousal 57 morphometric vertebral fractures 57 gastro esophageal reflux 57 venous stasis ulcers 57 Sleep Disturbance 57 symptomatic hyponatremia 57 Acute Heart Failure 57 Crit Rev 57 premenstrual dysphoric disorder PMDD 57 Prostatic 57 Beta Blocker 57 Kidney Function 57 generalized anxiety disorder GAD 57 Paroxysmal 57 Effective Treatments 57 thyroid dysfunction 57 Clinical Practice Guideline 57 epididymitis 57 HIV HCV coinfected 57 hypovitaminosis D 57 Improves Survival 57 venous thromboembolic disease 57 Parkinson Disease PD 57 SIADH 57 Idiopathic Pulmonary Fibrosis 57 alpha1 antitrypsin deficiency 57 postoperative delirium 57 Acute Decompensated Heart Failure 57 Myelodysplastic Syndromes 57 Neuroendocrine Tumors 57 postoperative atrial fibrillation 57 FDA Approvals 57 affective psychoses 57 Hemolysis 57 Subtypes 57 Systemic lupus erythematosus SLE 57 Percutaneous Tibial Nerve Stimulation 57 Thiazolidinediones 57 Sociodemographic 57 Arterial Disease 57 hyperprolactinemia 57 Renal Anemia 57 Cognitive Dysfunction 57 Treating Depression 57 urethral stricture 57 Acute Renal Failure 57 Cardiotoxicity 57 neurocognitive impairment 57 Erythropoietic therapies may 57 depression schizophrenia bipolar 57 Genetic Variation 57 Intracerebral 57 Demonstrate Significant 57 TMS Therapy 57 Synovial 57 Critical Limb Ischemia CLI 57 Autoimmune Disease 57 SGPT 57 Fibromyalgia Chronic Fatigue Syndrome 57 somatostatin analog 57 Initiates Enrollment 57 Demonstrates Sustained 57 Valve Replacement 57 Bi Polar Disorder 57 affective psychosis 57 Castration Resistant Prostate Cancer 57 Lymphoid 57 predisposing factor 57 Nat Genet 57 erythema nodosum 57 Phase IIb Clinical Trial 57 Chronic ITP 57 aminotransferases 57 Pediatric Patients 57 Subclinical 57 Pulmonary Arterial Hypertension 57 citalopram Celexa 57 Ankylosing spondylitis 57 Hip Fracture 57 subarachnoid hemorrhage SAH 57 chronic renal disease 57 euthymic patients 57 neurogenic bladder 57 Transdermal Delivery 57 Long Term Efficacy 57 Arch Pediatr Adolesc Med 57 Acute Myelogenous Leukemia 57 Cognitive Deficits 57 Patellofemoral 57 Psychodynamic 57 obstructive sleep apnea hypopnea 57 Clinical Decision Making 57 idiopathic scoliosis 57 Pivotal Phase III 57 Clostridium difficile Infection 57 Placebo Controlled Trial 57 Cardiovascular Events 57 serum phosphate 57 Low Incidence 57 Colorectal Adenomas 57 Aortic stenosis 56 Gestational Diabetes 56 Social Anxiety Disorder 56 Acute Ischemic Stroke 56 Selective serotonin reuptake inhibitors 56 Posttraumatic Stress 56 premenstrual dysphoric disorder 56 Desvenlafaxine Succinate 56 Cholesterol Levels SPARCL 56 Autoimmune Disorders 56 polyarticular 56 Esophageal 56 Acute Myeloid Leukaemia AML 56 Enlarged Prostate 56 #:#-#,# Medline 56 Acute Coronary Syndromes 56 CABG Surgery 56 sertraline Zoloft 56 Nicotine Vaccine 56 Atrial 56 Suicidal Behavior 56 constipation OIC 56 Myelodysplastic Syndrome 56 Adolescent Depression 56 Sjogren Syndrome 56 Nocturia 56 recurrent glioblastoma multiforme 56 #q# deletion syndrome 56 Stenosis 56 Arrhythmogenic 56 Asthma COPD 56 Study Evaluating 56 Oxidative Stress 56 antiphospholipid antibodies 56 Irritable Bowel 56 neurosensory 56 mania hypomania 56 Maven Semantic 56 Dilated Cardiomyopathy 56 Surgical Treatment 56 macular edema secondary 56 Interstitial Cystitis 56 autoimmune thyroid 56 Eye Diseases 56 Substance Dependence 56 relapsed MM 56 Severe Sepsis 56 BPH benign prostatic 56 #:#-#,# [001] 56 Lamotrigine 56 rheumatological 56 Chronic Lung 56 Echocardiographic 56 severe hepatic dysfunction 56 Sonographic 56 Surgical Procedures 56 MELAS 56 comorbid psychiatric 56 invasive candidiasis 56 artery stenosis 56 Gastrointestinal Stromal Tumors 56 Acute Promyelocytic Leukemia 56 STRIDE PD 56 reflux esophagitis 56 myomas 56 Previously Treated 56 venlafaxine XR 56 hypercalciuria 56 asymptomatic carotid stenosis 56 evaluating mipomersen 56 neuritic 56 #:#-# [037] 56 symptomatic intracranial 56 non splenectomized 56 Bronchiolitis 56 Patients Treated With 56 Lung Injury 56 Band 8a 56 monoclonal gammopathy 56 voiding dysfunction 56 renovascular hypertension 56 Wernicke Korsakoff syndrome 56 cholestasis 56 Coronary Angiography 56 left ventricular diastolic 56 Breast Cancers 56 shorter telomere length 56 vWD 56 Chronic Lymphocytic Leukemia 56 pharmacologic therapies 56 dysfunctional voiding 56 myeloproliferative neoplasms 56 hematological parameters 56 including eniluracil ADH 56 Well Tolerated 56 Polycystic ovary syndrome PCOS 56 thyroid deficiency 56 Aripiprazole 56 genetic syndromes 56 Epilepsy Drug 56 Clinical Trial Results 56 Borderline personality 56 neurological dysfunctions 56 chronic pelvic 56 bi polar disorders 56 Treatment Outcome 56 Premature Aging 56 Glucocorticoids 56 Arch Surg 56 depressive episodes associated 56 Aggressive Behavior 56 Chemotherapeutic Agents 56 benign prostatic hypertrophy BPH 56 acute postoperative 56 paroxysmal atrial fibrillation 56 comorbid disorders 56 chronic thromboembolic pulmonary 56 Decitabine 56 CNS Disorders 56 Obsessive compulsive disorder OCD 56 idiopathic PAH 56 paroxetine sertraline 56 Diagnosis Treatment 56 Bare Metal Stent 56 PEGINTRON TM 56 Prenatal Diagnosis 56 Inflammatory Diseases 56 Cognitive Function 56 Adult ADHD 56 Hyperthyroidism 56 Acne Rosacea 56 Educational Settings 56 INVEGA ® 56 Acute Coronary Syndromes ACS 56 moderate renal impairment 55 Hypothyroidism 55 DPNP 55 antiphospholipid syndrome 55 Ophena TM 55 invasive aspergillosis 55 thyrotropin levels 55 dysmenorrhea 55 Antiangiogenic 55 HER2 overexpression 55 Pervasive Developmental Disorder 55 Vascular Dementia 55 Disease Progression 55 Adverse Event 55 Leukemias 55 Warfarin Coumadin 55 idiopathic Parkinson disease 55 Demonstrated Significant 55 Laryngeal Cancer 55 Malformations 55 somatoform disorders 55 Multicenter Phase 55 Korsakoff syndrome 55 hyperreflexia 55 disorder Ketchmark 55 Interpersonal Psychotherapy 55 poststroke 55 orchitis 55 Genes Associated 55 Thyroid Cancer 55 Postmenopausal Women 55 Cardiac Rhythm 55 Ischaemic 55 Cognitive impairment 55 J Consult Clin 55 Genetic Mutation 55 Prolonged Exposure 55 Lennox Gastaut Syndrome 55 Keratitis 55 interstitial fibrosis 55 Mellaril 55 #:# -# [003] 55 Papillary 55 Osteomyelitis 55 postpartum mood 55 neurologic dysfunction 55 Hyperglycemia 55 intravascular hemolysis 55 serotonin norepinephrine reuptake inhibitor 55 chronic idiopathic thrombocytopenic purpura 55 Phase 2a Trial 55 coagulation abnormalities 55 Correlates 55 DSM IV Axis 55 Menopausal Women 55 rheumatologic 55 Lung Cancer Survival 55 Pulmonary embolism 55 decompensated liver disease 55 Statistically Significant 55 psychiatric comorbidity 55 Von Willebrand disease 55 Pharmaceuticals Initiates 55 Angiographic 55 Fibromyalgia syndrome 55 Pharmacodynamics 55 diabetes dyslipidemia 55 Genetic Basis 55 Bulimia Nervosa 55 Obstructive Sleep Apnoea 55 obstructive sleep 55 Parnate 55 orofacial pain 55 Polycystic Ovary Syndrome 55 Onychomycosis 55 Teriflunomide 55 proton MR spectroscopy 55 Antipsychotic 55 androgen depletion 55 post herpetic 55 aminotransferase 55 Follicular Lymphoma 55 adjuvant systemic 55 Circulatory Support 55 depressive symptomatology 55 ANCA associated 55 multi infarct dementia 55 Antiviral Therapy 55 Successfully Completes Phase 55 Autistic Disorder 55 Alzheimers Disease 55 Quetiapine 55 hyperlipidaemia 55 Neurodegenerative disorders 55 Presents Positive 55 heavy menstrual bleeding 55 sexual compulsivity 55 Lung Cancer Trial 55 Psychiatric Illness 55 Chronic sinusitis 55 chronic immune thrombocytopenic 55 Sexual Dysfunction 55 LYSTEDA 55 Hematological 55 Phase IIA 55 Rheumatoid Arthritis RA 55 Melasma 55 Ulcerative colitis 55 Intervention Effectiveness 55 Phase III Clinical Trial 55 Carbamazepine 55 Antipsychotic Medications 55 intracranial hypertension 55 Prostate Biopsy 55 Therapeutic Intervention 55 Irritable Bowel Syndrome IBS 55 Tonsillectomy 55 atypical Hemolytic Uremic Syndrome 55 tricyclic antidepressants TCAs 55 Patient Enrollment 55 Chronic Obstructive Pulmonary 55 dysuria 55 chronic venous insufficiency 55 Spinal Disc 55 Lubiprostone 55 Postoperative 55 Tasimelteon 55 J Virol 55 anterior uveitis 55 Prognostic Value 55 osteoporotic vertebral compression fractures 55 Chronic constipation 55 Oral mucositis 55 eosinophilia 55 Diabetic neuropathy 55 Magnesium deficiency 55 J Clin Psychiatry 55 psychiatric comorbidities 55 Diabetic Retinopathy 55 headache nasopharyngitis 55 overactive bladder symptoms 55 transfusion syndrome 55 attention-deficit/hyperactivity 55 Retreatment 55 Sanfilippo Syndrome 55 Bacterial vaginosis 55 undergoing peritoneal dialysis 55 Lung Function 55 polymyalgia rheumatica 55 ALT elevations 55 Ejection Fraction 55 Bipolar Disorder 55 Breast Cancer Treatment 55 Neurophysiological 55 depressive disorders 55 Depressive Disorders 55 myelofibrosis polycythemia vera 55 ALISTA 55 neurobehavioral disorder 55 overt nephropathy 55 Genetic Variations 55 Sexual Desire 55 Prostatitis 55 overactive bladder syndrome 55 Torsades de Pointes 55 Dysplasia 55 Initiates Phase III 55 inflammatory demyelinating 55 Seasonal affective disorder 55 Breast Tumors 55 Schizophrenia Treatment 55 Aortic Valve Replacement 55 pathophysiologic 55 Embolization 55 Genetic Marker 55 ALT flares 55 Pelvic Floor 55 Genetic Disorders 55 affective disorders 55 Morquio 55 somnolence dizziness 55 Pelvic Organ Prolapse 55 Predisposition 55 pouchitis 55 prolactin levels 55 Acute Treatment 55 Phase IIb Trial 55 Nilotinib 55 EFFEXOR XR 55 Peritoneal Mesothelioma 55 transcranial Doppler ultrasound 55 Hurler syndrome 55 intracerebral haemorrhage 55 mGluR2 positive 55 Excessive Daytime Sleepiness 55 Hemophilia B 55 Hemodialysis Patients 55 Sjögren syndrome 55 chronic prostatitis chronic 55 Clinical Evaluation 54 congenital deficiency 54 hormonal imbalance menopause 54 Hospitalized Patients 54 Sleep Duration 54 Osteoarthritis Patients 54 esophageal reflux 54 Neurodegenerative 54 Sipuleucel T 54 postoperative AF 54 decompensated heart failure 54 Posttraumatic stress disorder PTSD 54 osteoid osteoma 54 Oppositional Defiant Disorder 54 Electroconvulsive Therapy 54 osteoarthritis rheumatoid arthritis 54 Cognitive behavioral 54 Effexor venlafaxine 54 Body dysmorphic disorder 54 Mindfulness Based Cognitive Therapy 54 Showed Significant 54 Dual Antiplatelet Therapy 54 #:# -# [005] 54 dopamine antagonists 54 Acute Leukemia 54 Systolic Hypertension 54 Post Operative 54 Aneurysm Repair 54 Severe Asthma 54 Sexsomnia 54 recurrent abdominal pain 54 aMCI precursor 54 gravidarum 54 Interpersonal psychotherapy 54 Orthomolecular 54 Juvenile Rheumatoid Arthritis 54 neuropsychiatric disorder 54 infective endocarditis 54 Clinically significant 54 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 54 Statin Therapy 54 Improve Diagnosis 54 Novel Treatments 54 Venlafaxine 54 SHPT 54 cognitive impairment associated 54 paroxetine Paxil 54 Uterine 54 lumbar spinal stenosis LSS 54 Sexual Function 54 Wellbutrin bupropion 54 primary hyperparathyroidism 54 SEROQUEL R 54 choroidal neovascularization 54 Naive Patients 54 Brain Stimulation 54 Bucindolol 54 Autoantibodies 54 untreated obstructive sleep 54 Akathisia 54 chronic renal insufficiency 54 insomnia sleep apnea 54 Insulin Sensitivity 54 Electroencephalography 54 Borderline Personality Disorder 54 psychosis schizophrenia 54 Gene Variant 54 prospective multicenter study 54 Blood Pressure Monitoring 54 extrapyramidal symptoms 54 Zoloft sertraline 54 depressive disorder 54 pelvic prolapse 54 ACE Inhibitors 54 Anticonvulsant 54 Acute Pain 54 Investigational Compound 54 Natalizumab 54 Urogenital 54 polysubstance abuse 54 autoimmune thyroiditis 54 patientswith 54 CINQUIL 54 Benign Prostatic Hyperplasia BPH 54 Selective Serotonin Reuptake Inhibitor 54 clozapine Clozaril 54 varicoceles 54 Sleep disturbances 54 Stem Cell Treatment 54 BEXXAR Therapeutic Regimen 54 neurologic impairment 54 ziconotide 54 immune thrombocytopenic purpura ITP 54 metastatic GIST 54 neurocognitive deficits 54 Clinical Significance 54 Neovascularization 54 Diabetic Patients 54 Chronic Cough 54 abdominal adiposity 54 Skin sterol 54 disorder FSAD 54 #:#-# [007] 54 paranoia hallucinations 54 Premenstrual Dysphoric Disorder 54 hypokalemia hypomagnesemia 54 Immunosuppressive 54 biologic DMARD 54 Genetic Variant 54 giant cell arteritis 54 Hyperactivity 54 recurrent malignant glioma 54 immunodeficiencies 54 chronicity 54 Solid Tumor 54 OSAHS 54 Randomized Study 54 Dose Escalation 54 Fibromyalgia Syndrome FMS 54 molar pregnancy 54 PLMs 54 Lu AA# 54 Migraine Sufferers 54 Coronary CTA 54 Main Outcome Measure 54 Renal Cancer 54 Psychiatric Epidemiology 54 atherothrombotic 54 rheumatic disorders 54 urolithiasis 54 Tyrosine Kinase Inhibitor 54 Chronic Rhinosinusitis 54 fibromyalgia syndrome 54 neurologic deficits 54 diabetic gastroparesis 54 testicular germ cell 54 Shows Efficacy 54 Drug Candidate 54 Neuropsychological 54 Retinopathy 54 MEVACOR 54 Vaginal Infections 54 hemorrhagic pancreatitis 54 thrombophilia 54 perioperative complications 54 Thrombus 54 Restless Legs Syndrome RLS 54 coughing fatigue emaciation 54 fluoxetine paroxetine 54 psychiatry neurology 54 Cancer Biomarkers 54 sensory neuropathy 54 thyroid hormone replacement 54 BMC Musculoskeletal Disorders 54 Heritability 54 Vulvodynia 54 Practice Patterns 54 Acute Stress Disorder 54 HPA axis suppression 54 myeloproliferative disorders 54 Restless Legs Syndrome 54 Antiplatelet Therapy 54 Multicenter Trial 54 neuropsychiatric symptoms 54 Lipodystrophy 54 Cognitive Behavior Therapy 54 Tumor Response 54 Cerebral Cortex 54 leukemia AML 54 Relapse Prevention 54 neuroleptic 54 unstable angina UA 54 Pediatric Psychopharmacology 54 Neonatal Diabetes 54 benign paroxysmal positional vertigo 54 Postdoctoral Position 54 Hurthle cell 54 psychiatric morbidity 54 Hospital Acquired Pneumonia 54 Histologic 54 tic disorders 54 Antidepressant Use 54 Inflammatory Arthritis 54 Bosentan 54 Hepatitis C Virus 54 sub syndromal 54 Mitral Valve 54 myeloproliferative diseases 54 Placebo Controlled Study 54 Platelet Inhibition 54 bipolar affective disorder 54 variant angina 54 Toxicities 54 AGILECT R 54 acne vulgaris 54 refractory anaplastic astrocytoma 54 G6PD deficiency 54 multisystemic 54 Gastric Cancer 54 leukoencephalopathy 54 polycystic ovarian syndrome PCOS 54 proliferative diabetic retinopathy 54 chronic rhinosinusitis CRS 54 Bone Marrow Transplants 54 Chiari Malformation 54 Premature Birth 54 ASCUS 54 post herpetic neuralgia PHN 54 Nonsurgical 54 dysthymic 54 Malignant Melanoma 54 Low Testosterone 54 Adult Onset 54 dyspareunia 54 atherosclerotic renal artery stenosis 54 dissociative disorders 54 subsyndromal 54 percutaneous vertebroplasty 54 schizophrenia bipolar disorder 54 endometrial hyperplasia 54 Invasive Breast Cancer 54 OAB symptoms 54 Neurodevelopmental 54 Restless Legs 54 Myocardial Perfusion 54 Trigeminal neuralgia 54 Hypogonadism 54 Stent Thrombosis 54 Cervical Spine 54 FFR measurements 54 systemic hypotension 54 autonomic dysfunction 54 pseudobulbar affect PBA 54 reuptake inhibitor 54 Depression Anxiety 54 Transdermal Patch 54 INTEGRILIN R 54 HBV infections 54 Atrophic 54 ARIXTRA R 54 Mental Illnesses 54 hypoglycaemic episodes 54 atherothrombotic events 54 Hypoglycemia 54 Vaccine Immunology 54 abnormal lipid 54 pericardial effusion 54 dysthymia 54 Myocardial Perfusion Imaging 54 indicates cardio circulatory 54 Antipsychotic Drug 54 Celiac sprue